iTolerance

iTolerance is a privately held regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression.

03/11/2026

We are deeply saddened by the tragic and unexpected passing of our CEO and President, Anthony Japour. Anthony was not only a remarkable leader, but also someone whose warmth, generosity, and unwavering support left a lasting impact on all of us. Our hearts are with his family and loved ones during this incredibly difficult time. He will be deeply missed and forever remembered.

02/11/2026

Real stories. Real challenges. Real need for better solutions.
The Patient Journey video series shares firsthand experiences from those living with Type 1 Diabetes and the people who support them.

Hear more here: https://bit.ly/4qfl1pt

02/06/2026

Patient-first science powering regenerative breakthroughs for chronic disease.

01/28/2026

An estimated 100,000–135,000 people live with severe, uncontrolled Type 1 diabetes, a population in urgent need of better treatment options.

At iTolerance, we’re working to change that.

01/22/2026

Discover what sets iTolerance apart.

iTolerance is pioneering regenerative medicine without the need for life-long immunosuppression.

Our proprietary platform enables cell, organoid or tissue therapies with the potential to cure diseases like and beyond.

01/14/2026

Our CEO, Anthony Japour, is in San Francisco attending the J.P. Morgan Healthcare Conference, connecting with investors and industry leaders around the future of regenerative medicine.

To schedule a meeting, please contact [email protected].

01/09/2026

We’ll be in San Francisco, CA, January 12–15 during the J.P. Morgan Healthcare Conference and look forward to connecting with industry leaders.

To schedule a meeting, please contact [email protected].

01/08/2026

Take a deeper dive into our science!
Check out our scientific publications here: https://bit.ly/3YAUqcl

01/06/2026

: Brittle diabetes can cause extreme swings in blood sugar levels. Severe hypoglycemia isn’t just dangerous; it can lead to seizures, coma, heart complications, and even be life-threatening. Raising awareness is essential.

12/31/2025

Happy New Year from iTolerance! May 2026 bring you success and good health.

12/23/2025

Wishing you joy, health and time spent with those who matter most!

Address

1951 NW 7th Avenue
Miami, FL
33136

Website

http://www.itolerance.com/

Alerts

Be the first to know and let us send you an email when iTolerance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to iTolerance:

Shortcuts

Want your business to be the top-listed Engineering Company in Miami?